How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

Amanda Cole;Adrian Towse;Michelle Mujoomdar;Arnold Chan;Franz Pichler
Authors registered in the RePEc Author Service: Adrian Towse and Amanda Megan Cole ()

Briefing from Office of Health Economics

Abstract: This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting, Tokyo. The panel session was entitled "How Can HTA in Asia-Pacific Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?" and was chaired by Franz Pichler (Eli Lilly & Company).

Keywords: How; Can; Health; Technology; Assessments; in; the; Asia-Pacific; Area; Respond; to; Increased; Clinical; Uncertainty; as; a; Consequence; of; Expedited; US; and; EU; Regulatory; Processes? (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2016-08-01
New Economics Papers: this item is included in nep-hea and nep-sea
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/how-can-health-te ... rtainty-august-2016/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:briefg:001740

Access Statistics for this paper

More papers in Briefing from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).